Key result
Cardioneuroablation for vasovagal syncope shows ~44% recurrence, dropping with three favorable procedural markers.
Why the study?
Cardioneuroablation is increasingly used for recurrent vasovagal syncope, but the optimal procedural approach and acute endpoints remain unclear.
Are physiological markers of effective autonomic denervation associated with reduced recurrence of syncope after cardioneuroablation in patients with refractory vasovagal syncope?
Cohort (n=57)
Are physiological markers of effective autonomic denervation associated with reduced recurrence of syncope after cardioneuroablation in patients with refractory vasovagal syncope?
Achieving specific physiological endpoints during cardioneuroablation, such as a vagal response and increased sinus rate, is associated with a lower risk of recurrent vasovagal syncope.
Recurrence after cardioneuroablation remains high; supports marker-guided selection but leaves open randomized confirmation of benefit.
BACKGROUND: Cardioneuroablation (CNA) has been increasingly pursued as a treatment for patients with recurrent vasovagal syncope. The optimal procedural approach and acute endpoints are unclear. OBJECTIVE: The goal of this study was to characterize procedural markers linked to durable freedom from syncope. METHODS: All patients who underwent CNA for vasovagal syncope refractory to lifestyle modification with at least 1 year of follow-up were included in a retrospective cohort. Clinical and procedural characteristics were analyzed for association with recurrence of syncope. RESULTS: A total of 57 patients (mean age 39.8 ± 10.7 years; 53% female; 6.7 ± 3.8 episodes of syncope in the prior year) met inclusion criteria. During 2.2 ± 0.8 years of follow-up, 25 patients (44%) had recurrent syncope. Symptomatic inappropriate sinus tachycardia occurred in 14% and was more common after CNA guided by extracardiac vagal stimulation (64% vs 2%). Patients who remained free from recurrent syncope were more likely to exhibit a vagal response during ablation of the left-sided ganglionated plexus (56% vs 12%; P = 0.001), had a greater increase in sinus rate during the ablation (29.9 ± 15.1 beats/min vs 10.0 ± 15.8 beats/min; P = 0.01), and were less likely to exhibit a positive atropine response at the end of the procedure (3% vs 24%; P = 0.04). Patients who exhibited a greater number of these favorable physiological markers had progressively lower rates of recurrent syncope. Patients meeting all 3 criteria had the lowest recurrence rate (14%). CONCLUSIONS: There is a substantial rate of recurrent syncope after CNA with intermediate-term follow-up. Inadequate acute procedural endpoints may be associated with recurrence.
No takes yet. Share an insight, caveat, or question.
Vojnika et al. (2026) conducted a cohort in Vasovagal syncope (n=57). Cardioneuroablation was evaluated on Recurrence of syncope. Cardioneuroablation for vasovagal syncope was associated with a 44% rate of recurrent syncope over 2.2 years, though recurrence was only 14% in patients exhibiting three favorable procedural markers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: